Metacavir

DB19084InvestigationalSmall molecule

Metacavir is under investigation in clinical trial NCT02965859 (The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B).

Formula / weight: C₁₁H₁₅N₅O₃ · 265.273 g/mol (avg)
Also known as: ((2s,5r)-5-(2-amino-6-methoxy-purin-9-yl)tetrahydrofuran-2-yl)methanol · 2',3'-dideoxy-6-o-methylguanosine · Guanosine, 2',3'-dideoxy-6-o-methyl-
Code names: PNA

Resolves to

Compound

UNIIW5EOS3V193CAS120503-45-9ChEMBLCHEMBL243716

Structure

InChIKeyFJAOCNGVPLTSLD-NKWVEPMBSA-NSMILESCOC1=C2N=CN([C@H]3CC[C@@H](CO)O3)C2=NC(N)=N1

What you can answer from here — as of July 04, 2024

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Metacavir, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account